Search
for
Sort by
Research 121–150 of 1000+
- Androgens Affect the Activity of Human Sebocytes in Culture in a Manner Dependent on the Localization of the Sebaceous Glands and Their Effect Is Antagonized by Spironolactone
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Hirsutism in the Adolescent Female
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Androgen Treatment in Women
- 11 Treatment of hirsutism and acne with cyproterone acetate
- 312 CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
- CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Toward a Diagnostic Score in Cushing's Syndrome
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- How should postmenopausal androgen excess be evaluated?
- Endocrine evaluation of hirsutism
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Effective medical treatment for common baldness in women
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Androgen treatment of postmenopausal women
- Lifestyle and Physiological Factors Associated with Facial Wrinkling in Men and Women